Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BeyondSpring Inc.BYSI · Entity 7539 | Chief Scientific Officer | April 01, 2026 | April 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BeyondSpring Inc.
Report date April 01, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.64 · Expires 2036-04-01 | Direct | 17,840 |
Reported balance
After 2026-04-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-01 · Grant · Acquired 17,840 · Balance 17,840 F1: Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 4,460 of the stock options will vest on each of April 1, 2027, April 1, 2028, April 1, 2029 and April 1, 2030, subject to the Reporting Person's continuous service with the Issuer through such dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 4,460 of the stock options will vest on each of April 1, 2027, April 1, 2028, April 1, 2029 and April 1, 2030, subject to the Reporting Person's continuous service with the Issuer through such dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 3, 2026 20:24 UTC | BeyondSpring Inc. BYSI · Entity 7539 | GrantStock Options (right to buy) · Derivative | 17,840 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001193125-26-142216 · ownership.xml · derivative · entry 1 Lu Yingjuan June · CIK 0002050151 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,840 Underlying: Ordinary Shares · 17,840 shares Expires 2036-04-01 F1 · derivative.exercise_date: Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 4,460 of the stock options will vest on each of April 1, 2027, April 1, 2028, April 1, 2029 and April 1, 2030, subject to the Reporting Person's continuous service with the Issuer through such dates. Read SEC document |
| April 21, 2025 Filed Apr 23, 2025 12:57 UTC | BeyondSpring Inc. BYSI · Entity 7539 | GrantStock Options (right to buy) · Derivative | 18,981 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0000950170-25-056984 · ownership.xml · derivative · entry 1 Lu Yingjuan June · CIK 0002050151 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,981 Underlying: Ordinary Shares · 18,981 shares Expires 2035-04-21 F1 · derivative.exercise_date: Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All of the stock options will vest on April 21, 2026, subject to the Reporting Person's continuous service with the Issuer through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.